Section 38: Offences by companies

Narcotic Drugs and Psychotropic Substances Act, 1985 • Official Statutory Text & Practice Guide

Statutory Regulation
Legal Standard
Competent Court / Tribunal
Act 1985

Legal Commentary & Landmark Judgments: Section 38

Section 38 of the NDPS Act establishes statutory corporate criminal liability, deeming both the company and every person in charge of and responsible to it for the conduct of its business guilty of offences under Chapter IV, while providing a statutory defense of lack of knowledge or due diligence.

  • Deemed Vicarious Criminal Liability: Where an offence under Chapter IV is committed by a company, the company as well as every person who was in charge of and responsible for the conduct of its business at the time of the offence is deemed guilty under Section 38(1).
  • Statutory Defense of Due Diligence: Proviso to Section 38(1) provides complete immunity if the accused individual proves that the offence was committed without their knowledge or that they exercised all due diligence to prevent it.
  • Specific Officer Culpability: Section 38(2) penalizes any director, manager, secretary, or other officer if it is proved that the offence occurred with their consent, connivance, or was attributable to neglect.
Key Landmark Precedents:
  • Sunil Bharti Mittal v. CBI (2015) 4 SCC 609: The Supreme Court held that vicarious liability cannot be imputed to corporate directors in criminal law unless there is specific statutory provision and concrete evidence of individual culpability or active role.
  • S.M.S. Pharmaceuticals Ltd. v. Neeta Bhalla (2005) 8 SCC 89: The Supreme Court reaffirmed that complaint/charge-sheet must contain specific factual averments showing that the named director was actively in charge of day-to-day business at the crucial time.
Courtroom Practice & Strategic Litigation Guidance:

For non-executive directors, independent directors, or nominee directors named in pharmaceutical NDPS complaints, immediately file a quashing petition under Section 482 CrPC (Section 528 BNSS) citing Sunil Bharti Mittal and S.M.S. Pharmaceuticals, demonstrating the absence of specific averments regarding day-to-day operational control and pleading the due diligence proviso under Section 38(1).